Literature DB >> 6125772

Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation.

R A Clift, C D Buckner, E D Thomas, K Doney, A Fefer, P E Neiman, J Singer, J Sanders, P Stewart, K M Sullivan, J Deeg, R Storb.   

Abstract

Ten patients with chronic granulocytic leukaemia in the chronic phase have been treated with chemoradiotherapy followed by transplantation of bone marrow from HLA-identical siblings. Engraftment was achieved in all patients, and Philadelphia chromosome disappeared from the nine patients who had it before transplantation. Four patients have died, three with interstitial pneumonitis and one with severe graft-versus-host disease (GvHD). Six patients are alive and well in complete clinical, cytogenetic, and haematological remission, 1-3 years after transplantation, despite complications in three patients (one had interstitial pneumonitis, one had mild veno-occlusive disease of the liver, and one had severe GvHD).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125772     DOI: 10.1016/s0140-6736(82)92735-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

Review 1.  We do still transplant CML, don't we?

Authors:  Charles F Craddock
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party.

Authors:  C Koenecke; D Heim; A van Biezen; M Heuser; M Aljurf; S Kyrcz-Krzemien; L Volin; C A de Souza; T Gedde-Dahl; H Sengeloev; U Schanz; M Komarnicki; C H Arroyo; E Tholouli; E Gluckman; A Esquirol; I Yakoub-Agha; G Gürman; E Olavarria; N Kröger
Journal:  Bone Marrow Transplant       Date:  2016-04-25       Impact factor: 5.483

Review 3.  Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.

Authors:  Nitin Jain; Koen van Besien
Journal:  Hematol Oncol Clin North Am       Date:  2011-10       Impact factor: 3.722

Review 4.  The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century.

Authors:  A John Barrett; Sawa Ito
Journal:  Blood       Date:  2015-04-07       Impact factor: 22.113

5.  Bone marrow transplantation beyond treatment of aplasia and neoplasia.

Authors:  E Beutler
Journal:  West J Med       Date:  1994-02

Review 6.  Bone marrow transplantation: 1982.

Authors:  H E Kay
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-06

7.  Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia.

Authors:  T G Sutedja; J F Apperley; J M Hughes; V R Aber; H G Kennedy; P Nunn; L Jones; L Hopper; J M Goldman
Journal:  Thorax       Date:  1988-03       Impact factor: 9.139

8.  Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.

Authors:  Edward A Copelan; Belinda R Avalos; Kwang Woo Ahn; Xiaochun Zhu; Robert Peter Gale; Michael R Grunwald; Mehdi Hamadani; Betty K Hamilton; Gregory A Hale; David I Marks; Edmund K Waller; Bipin N Savani; Luciano J Costa; Muthalagu Ramanathan; Jean-Yves Cahn; H Jean Khoury; Daniel J Weisdorf; Yoshihiro Inamoto; Rammurti T Kamble; Harry C Schouten; Baldeep Wirk; Mark R Litzow; Mahmoud D Aljurf; Koen W van Besien; Celalettin Ustun; Brian J Bolwell; Christopher N Bredeson; Omotayo Fasan; Nilanjan Ghosh; Mary M Horowitz; Mukta Arora; Jeffrey Szer; Alison W Loren; Edwin P Alyea; Jorge Cortes; Richard T Maziarz; Matt E Kalaycio; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-17       Impact factor: 5.742

9.  Bone marrow transplantation for chronic granulocytic leukaemia.

Authors:  H K Mahmoud; U W Schaefer; F Schüning; D Beelen; R Becher; C G Schmidt; W Alberti; E Haralambie; G Linzenmeier; B Stollmann
Journal:  Klin Wochenschr       Date:  1985-06-18

10.  Recombinant human interferon-alpha induced cytoreduction in chronic myelogenous leukemia. Results of a multicenter study.

Authors:  M Werter; R de Witte; J Janssen; B de Pauw; C Haanen
Journal:  Blut       Date:  1988-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.